GlassScriptPhysician profile
Matthew W Harris
NPI 1154314029
$8,590.54
in general payments reported to CMS, 2019-2025
49 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,027 · 2020: $180 · 2021: $862 · 2022: $1,261 · 2023: $2,017 · 2024: $1,995 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,261.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,427.79 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $1,046.25 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $772.51 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $651.02 | 2019-2024 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $551.23 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $402.05 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $389.49 | 2019-2024 | Jardiance, Ofev |
| Pfizer INC. | $380.02 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $266.76 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $239.06 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $224.41 | 2021-2025 | |
| Allergan, INC. | $203.62 | 2019 | |
| Exact Sciences Corporation | $152.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $150.52 | 2022-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $148.72 | 2021-2023 | Gattex, Trintellix |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.